Firdapse

settlement
Pharma

Catalyst's Teva settlement postpones arrival of Firdapse generic

Thanks to a new settlement with Catalyst, Teva is barred from marketing its Firdapse generic in the U.S. until Feb. 25, 2035, at the earliest.
Fraiser Kansteiner Jan 9, 2025 10:08am
Eisai new US headquarters

Eisai peddles US rights to epilepsy drug Fycompa to Catalyst

Dec 20, 2022 10:35am
FDA

Catalyst one-ups Jacobus, FDA in Firdapse exclusivity appeal

Oct 1, 2021 12:11pm
courthouse

Catalyst sues FDA over 'capricious' approval for rival

Jun 12, 2019 10:45am
FDA

Catalyst's $375K Firdapse could get off-label competition

May 7, 2019 12:02pm
Drug prices healthcare costs pill money

Patient group urges BIO to boot Catalyst over $375K Firdapse price

Mar 7, 2019 10:20am